Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

HKPD stock hub

Cellyan Biotechnology Co., Ltd has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKPDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

14.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

HKPD

In the news

Latest news · HKPD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-13.4

P25 -106.6P50 -46.9P75 -3.1

ROIC-12.6

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKPD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002007702
Company name	Cellyan Biotechnology Co., Ltd
Country	Hong Kong
Country code	US
Cusip	G6365B104
Employees	27
Employees Change	8%
Employees Change Percent	42.11
Enterprise value	$14.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Distribution
IPO Date	2025-01-15
Isin	KYG6365B1041
Last refreshed	2026-05-10
Market cap	$14.6M
Market cap category	Nano-Cap
Price	$0.62
Price currency	USD
Rev Per Employee	605,917.37x
Sector	Healthcare
Sic	5122
Symbol	HKPD
Website	https://www.9zt.hk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.8%
EV/Sales	0.88x
FCF yield	-3.37%
P/B ratio	1.33x
P/S ratio	0.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-3.81%
EBITDA Margin	-3.27%
Gross margin	8.8%
Gross Profit	$1.4M
Gross Profit Growth	-65.11%
Gross Profit Growth Q	-30.33%
Net Income	$-701,880
Net Income Growth Q	-81.45%
Net Income Growth Years	0%
Pretax Margin	-4.71%
Profit Margin	-4.29%
Profit Per Employee	$-25,996
ROA	-3.94
ROCE	-9.44
ROE	-13.37
ROIC	-12.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-29.31%
EPS Growth Q	-83.13
EPS Growth Years	0
Revenue Growth	-21.24x
Revenue Growth Q	-35.65x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.65
Assets	$9.6M
Cash	$2.5M
Current Assets	$8.9M
Current Liabilities	$3M
Debt	$2.3M
Debt EBITDA	$4.86
Debt Equity	$0.44
Equity	$5.1M
Interest Coverage	-5.6
Liabilities	$4.5M
Long Term Assets	$776,298
Long Term Liabilities	$1.5M
Net Cash	$208,650
Net Cash By Market Cap	$1.43
Net Debt Equity	$-0.04
Tangible Book Value	$5.1M
Tangible Book Value Per Share	$0.46

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.93
Inventory Turnover	25.97
Net Working Capital	$4.2M
Quick ratio	2.51
Working Capital	$5.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-19.69%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-29.29%
200-day SMA	0.95
50-day SMA	0.64
50-day SMA vs 200-day SMA	50under200
All Time High	3.79
All Time High Change	-83.58%
All Time High Date	2025-01-15
All Time Low	0.37
All Time Low Change	68.22%
All Time Low Date	2026-03-30
ATR	0.07
Beta1y	1.39
Beta2y	1.14
Ch YTD	-24.5
High	0.7
High52	2.76
High52 Date	2025-06-02
High52ch	-77.45%
Low	0.56
Low52	0.37
Low52 Date	2026-03-30
Low52ch	68.22%
Ma50ch	-2.2%
Price vs 200-day SMA	-34.72%
RSI	45.11
RSI Monthly	24.89
RSI Weekly	38.11
Sharpe ratio	0.26x
Sortino ratio	0.53
Total Return	-19.69%
Tr YTD	-24.5
Tr1m	19.69%
Tr1w	-9.14%
Tr3m	-24.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-623,584
Operating Income Growth Q	-37.69
Operating margin	-3.81

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,713,668%
Float Percent	66.87%
Net Borrowing	-478,830
Shares Insiders	33.13%
Shares Institutions	0.31%
Shares Out	23,499,986
Shares Qo Q	5.66%
Shares Yo Y	19.69%
Short Float	0%
Short Ratio	0.02
Short Shares	0

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-492,236
Average Volume	19,192.75x
Bv Per Share	0.47
CAPEX	$-64,314
Ch1m	19.69
Ch1w	-9.14
Ch1y	-29.29
Ch3m	-24.74
Ch6m	-48.56
Change	-2.75%
Change From Open	5.49
Close	0.64
Days Gap	-7.81
Depreciation Amortization	89,106
Dollar Volume	10,282.7
Earnings Date	2026-03-18
Earnings Time	amc
EBIT	$-623,584
EBITDA	$-534,478
EPS	$-0.07
F Score	2
FCF	$-492,236
FCF EV Yield	-3.41x
FCF Per Share	$-0.02
Financing CF	2,637,583
Fiscal Year End	March
Founded	2,016
Income Tax	$-69,068
Investing CF	-2,391,119
Ipr	-84.44
Iprfo	-82.22
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-18
Last Report Date	2025-09-30
Last Split Type	Never
Last10k Filing Date	2025-08-14
Ma150	0.85
Ma150ch	-26.7%
Ma20	0.67
Ma20ch	-6.45%
Net CF	-174,020
Next Earnings Date	2026-08-14
Open	0.59
Optionable	No
Position In Range	46.85
Post Close	0.62
Postmarket Change Percent	-7.39
Postmarket Price	$0.58
Ppne	686,080
Price Date	2026-05-08
Ptbv Ratio	2.89
Relative Volume	0.86x
Revenue	16,359,769x
Tax By Revenue	-0.42x
Tr6m	-48.56%
Volume	16,521
Z Score	4.52

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKPD pay a dividend?

Capital-return profile for this ticker.

Performance

HKPD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKPD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Float: +66.9% of shares outstanding

Insider ownership

+33.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

HKPD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

45.1

Neutral momentum band

Price vs 200-day MA

-34.7%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.26

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKPD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current HKPD stock rating?

Cellyan Biotechnology Co., Ltd is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full HKPD analysis?

The full report lives at /stocks/HKPD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for HKPD?

The latest report frames HKPD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the HKPD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.